We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nastech Pharmaceutical Company (MM) | NASDAQ:NSTK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.19 | 0 | 01:00:00 |
Delaware | 0-13789 | 11-2658569 | ||
(State or other | (Commission | (I.R.S. Employer | ||
jurisdiction of incorporation) | File Number) | Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
NASTECH PHARMACEUTICAL COMPANY INC.
By:
/s/ Dr. Steven C. Quay
Name:
Steven C. Quay, M.D., Ph.D.
Title:
Chairman of the Board and
Chief Executive Officer
Exhibit No.
Description
Transcript of Conference Call of Nastech Pharmaceutical
Company Inc. held on March 3, 2008
1 Year Nastech Pharmaceutical Company (MM) Chart |
1 Month Nastech Pharmaceutical Company (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions